Labopharm gets $10m debt financing
The firm said it will use the proceeds from the financing for its general corporate purposes, including the commercialization of its pain relief medicine tramadol in Europe. Hercules
US-based biotechnology company Superluminal Medicines has completed a $60m Series B financing round to support its research into therapies for rare genetic forms of obesity and hypothalamic obesity.